Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Total Current Liabilities (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Total Current Liabilities for 16 consecutive years, with $18.3 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 6.3% to $18.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, down 6.3% year-over-year, with the annual reading at $18.3 million for FY2025, 6.3% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $18.3 million at Gyre Therapeutics, up from $15.9 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $20.0 million in Q4 2023, with the low at $1.6 million in Q3 2022.
  • Average Total Current Liabilities over 5 years is $13.2 million, with a median of $15.1 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities crashed 90.47% in 2022, then soared 725.35% in 2024.
  • Over 5 years, Total Current Liabilities stood at $14.2 million in 2021, then fell by 13.58% to $12.2 million in 2022, then soared by 63.76% to $20.0 million in 2023, then dropped by 2.65% to $19.5 million in 2024, then fell by 6.3% to $18.3 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $18.3 million, $15.9 million, and $16.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.